Thesunrisetime › Investing › RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Investing 04-06-2025 02:11 4 Views

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Other news

05-06-2025 16:11

Bold Ventures Announces Further Increase of Non-brokered Private Placement

05-06-2025 16:11

Red Metal Resources Provides Update on Results of Mapping Program on Its Carrizal IOCG Property

Enter Your Information Below To Receive Latest News, And Articles.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!